Cargando…
Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors
High-dose chemotherapy with autologous hematopoietic stem cell transplantation (autoHSCT) is a well-established treatment for pediatric central nervous system (CNS) tumors. Given the risks of toxicity and infection, pediatric autoHSCT has been historically performed on hospitalized children. As our...
Autores principales: | Koo, Jane, Silverman, Stacy, Nuechterlein, Brandon, Keating, Amy K., Verneris, Michael R., Foreman, Nicholas K., Mulcahy Levy, Jean M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957458/ https://www.ncbi.nlm.nih.gov/pubmed/30783209 http://dx.doi.org/10.1038/s41409-019-0479-3 |
Ejemplares similares
-
QOL-36. USE OF CANNABINOIDS IN THE PEDIATRIC CENTRAL NERVOUS SYSTEM TUMOR POPULATION
por: Dorris, Kathleen, et al.
Publicado: (2020) -
Using BRAF(V600E) as a marker of autophagy dependence in pediatric brain tumors
por: Levy, Jean M Mulcahy, et al.
Publicado: (2014) -
Radiation Therapy for Young Children Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant for Primary Brain Tumors
por: Milgrom, Sarah A., et al.
Publicado: (2022) -
Emerging evidence of anti-tumor immune control in the central nervous system
por: Donson, Andrew M., et al.
Publicado: (2012) -
Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment
por: Koo, Jane, et al.
Publicado: (2020)